Antimicrobial Resistance Surveillance Methods in Bangladesh : Present and Way Forward
© The Author(s) 2023. Published by Oxford University Press on behalf of Infectious Diseases Society of America..
The Institute of Epidemiology, Disease Control and Research (IEDCR) conducts active, case-based national antimicrobial resistance (AMR) surveillance in Bangladesh. The Capturing Data on Antimicrobial Resistance Patterns and Trends in Use in Regions of Asia (CAPTURA) project accessed aggregated retrospective data from non-IEDCR study sites and 9 IEDCR sites to understand the pattern and extent of AMR and to use analyzed data to guide ongoing and future national AMR surveillance in both public and private laboratories. Record-keeping practices, data completeness, quality control, and antimicrobial susceptibility test practices were investigated in all laboratories participating in case-based IEDCR surveillance and laboratory-based CAPTURA sites. All 9 IEDCR laboratories recorded detailed case-based data (n = 16 816) in electronic format for a priority subset of processed laboratory samples. In contrast, most CAPTURA sites (n = 18/33 [54.5%]) used handwritten registers to store data. The CAPTURA sites were characterized by fewer recorded variables (such as patient demographics, clinical history, and laboratory findings) with 1 020 197 individual data, less integration of patient records with the laboratory information system, and nonuniform practice of data recording; however, data were collected from all available clinical samples. The analyses conducted on AMR data collected by IEDCR and CAPTURA in Bangladesh provide current data collection status and highlight opportunities to improve ongoing data collection to strengthen current AMR surveillance system initiatives. We recommend a tailored approach to conduct AMR surveillance in high-burden, resource-limited settings.
| Medienart: |
E-Artikel |
|---|
| Erscheinungsjahr: |
2023 |
|---|---|
| Erschienen: |
2023 |
| Enthalten in: |
Zur Gesamtaufnahme - volume:77 |
|---|---|
| Enthalten in: |
Clinical infectious diseases : an official publication of the Infectious Diseases Society of America - 77(2023), Suppl 7 vom: 20. Dez., Seite S549-S559 |
| Sprache: |
Englisch |
|---|
| Beteiligte Personen: |
Sujan, Mohammad Julhas [VerfasserIn] |
|---|
| Links: |
|---|
| Themen: |
AMR surveillance |
|---|
| Anmerkungen: |
Date Completed 22.12.2023 Date Revised 03.04.2024 published: Print Citation Status MEDLINE |
|---|
| doi: |
10.1093/cid/ciad561 |
|---|
| funding: |
|
|---|---|
| Förderinstitution / Projekttitel: |
|
| PPN (Katalog-ID): |
NLM366086766 |
|---|
| LEADER | 01000caa a22002652 4500 | ||
|---|---|---|---|
| 001 | NLM366086766 | ||
| 003 | DE-627 | ||
| 005 | 20240403235134.0 | ||
| 007 | cr uuu---uuuuu | ||
| 008 | 231227s2023 xx |||||o 00| ||eng c | ||
| 024 | 7 | |a 10.1093/cid/ciad561 |2 doi | |
| 028 | 5 | 2 | |a pubmed24n1363.xml |
| 035 | |a (DE-627)NLM366086766 | ||
| 035 | |a (NLM)38118018 | ||
| 040 | |a DE-627 |b ger |c DE-627 |e rakwb | ||
| 041 | |a eng | ||
| 100 | 1 | |a Sujan, Mohammad Julhas |e verfasserin |4 aut | |
| 245 | 1 | 0 | |a Antimicrobial Resistance Surveillance Methods in Bangladesh |b Present and Way Forward |
| 264 | 1 | |c 2023 | |
| 336 | |a Text |b txt |2 rdacontent | ||
| 337 | |a ƒaComputermedien |b c |2 rdamedia | ||
| 338 | |a ƒa Online-Ressource |b cr |2 rdacarrier | ||
| 500 | |a Date Completed 22.12.2023 | ||
| 500 | |a Date Revised 03.04.2024 | ||
| 500 | |a published: Print | ||
| 500 | |a Citation Status MEDLINE | ||
| 520 | |a © The Author(s) 2023. Published by Oxford University Press on behalf of Infectious Diseases Society of America. | ||
| 520 | |a The Institute of Epidemiology, Disease Control and Research (IEDCR) conducts active, case-based national antimicrobial resistance (AMR) surveillance in Bangladesh. The Capturing Data on Antimicrobial Resistance Patterns and Trends in Use in Regions of Asia (CAPTURA) project accessed aggregated retrospective data from non-IEDCR study sites and 9 IEDCR sites to understand the pattern and extent of AMR and to use analyzed data to guide ongoing and future national AMR surveillance in both public and private laboratories. Record-keeping practices, data completeness, quality control, and antimicrobial susceptibility test practices were investigated in all laboratories participating in case-based IEDCR surveillance and laboratory-based CAPTURA sites. All 9 IEDCR laboratories recorded detailed case-based data (n = 16 816) in electronic format for a priority subset of processed laboratory samples. In contrast, most CAPTURA sites (n = 18/33 [54.5%]) used handwritten registers to store data. The CAPTURA sites were characterized by fewer recorded variables (such as patient demographics, clinical history, and laboratory findings) with 1 020 197 individual data, less integration of patient records with the laboratory information system, and nonuniform practice of data recording; however, data were collected from all available clinical samples. The analyses conducted on AMR data collected by IEDCR and CAPTURA in Bangladesh provide current data collection status and highlight opportunities to improve ongoing data collection to strengthen current AMR surveillance system initiatives. We recommend a tailored approach to conduct AMR surveillance in high-burden, resource-limited settings | ||
| 650 | 4 | |a Journal Article | |
| 650 | 4 | |a Research Support, Non-U.S. Gov't | |
| 650 | 4 | |a AMR surveillance | |
| 650 | 4 | |a Bangladesh | |
| 650 | 4 | |a active surveillance | |
| 650 | 4 | |a case-based surveillance | |
| 650 | 4 | |a laboratory-based surveillance | |
| 650 | 7 | |a Anti-Bacterial Agents |2 NLM | |
| 700 | 1 | |a Habib, Zakir Hossain |e verfasserin |4 aut | |
| 700 | 1 | |a Rahman, Aninda |e verfasserin |4 aut | |
| 700 | 1 | |a Rizvi, S M Shahriar |e verfasserin |4 aut | |
| 700 | 1 | |a Barua, Hridika Talukder |e verfasserin |4 aut | |
| 700 | 1 | |a Aboushady, Ahmed Taha |e verfasserin |4 aut | |
| 700 | 1 | |a Hasnat, Md Abul |e verfasserin |4 aut | |
| 700 | 1 | |a Rasul, Saima Binte Golam |e verfasserin |4 aut | |
| 700 | 1 | |a Joh, Hea Sun |e verfasserin |4 aut | |
| 700 | 1 | |a Prifti, Kristi |e verfasserin |4 aut | |
| 700 | 1 | |a Chi, Kyu-Young Kevin |e verfasserin |4 aut | |
| 700 | 1 | |a Kwon, Soo Young |e verfasserin |4 aut | |
| 700 | 1 | |a Clark, Adam |e verfasserin |4 aut | |
| 700 | 1 | |a Gautam, Sanjay |e verfasserin |4 aut | |
| 700 | 1 | |a Holm, Marianne |e verfasserin |4 aut | |
| 700 | 1 | |a Marks, Florian |e verfasserin |4 aut | |
| 700 | 1 | |a Stelling, John |e verfasserin |4 aut | |
| 700 | 1 | |a Shaw, Alina |e verfasserin |4 aut | |
| 700 | 1 | |a Poudyal, Nimesh |e verfasserin |4 aut | |
| 773 | 0 | 8 | |i Enthalten in |t Clinical infectious diseases : an official publication of the Infectious Diseases Society of America |d 1992 |g 77(2023), Suppl 7 vom: 20. Dez., Seite S549-S559 |w (DE-627)NLM012603007 |x 1537-6591 |7 nnns |
| 773 | 1 | 8 | |g volume:77 |g year:2023 |g number:Suppl 7 |g day:20 |g month:12 |g pages:S549-S559 |
| 856 | 4 | 0 | |u http://dx.doi.org/10.1093/cid/ciad561 |3 Volltext |
| 912 | |a GBV_USEFLAG_A | ||
| 912 | |a GBV_NLM | ||
| 951 | |a AR | ||
| 952 | |d 77 |j 2023 |e Suppl 7 |b 20 |c 12 |h S549-S559 | ||